Corbus Pharmaceuticals Holdings (CRBP) Other Working Capital Changes (2015 - 2025)
Corbus Pharmaceuticals Holdings' (CRBP) quarterly Other Working Capital Changes came in at -$407000.0 in Q3 2025, down 11.51% year-on-year from -$459922.6 in Q3 2024, and down 2.01% quarter-over-quarter from -$399000.0 in Q2 2025.
Corbus Pharmaceuticals Holdings (CRBP) Other Working Capital Changes (2015 - 2025) Analysis & Trends
Corbus Pharmaceuticals Holdings' Other Working Capital Changes history runs 2 years deep, the most recent figure standing at -$29.5 million for Q2 2019.
- On a quarterly basis, Other Working Capital Changes fell 11.51% year-over-year to -$407000.0 in Q3 2025; TTM through Sep 2025 was -$1.6 million, a 11.66% decrease from a year earlier, with the FY2024 full-year figure at -$1.4 million, down 12.18% from the prior year.
- Other Working Capital Changes declined to -$29.5 million in Q2 2019 per CRBP's latest filing, from $25.5 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at -$237592.0 in Q1 2021 and bottomed at -$407000.0 in Q3 2025.
- The 5-year median for Other Working Capital Changes is -$319263.0 (2023), against an average of -$318368.9.
- Biggest YoY gain for Other Working Capital Changes was 13.66% in 2021; the steepest drop was 235.19% in 2021.
- Year by year, Other Working Capital Changes stood at -$260600.0 in 2021, then slipped by 13.13% to -$294821.0 in 2022, then fell by 12.61% to -$332000.0 in 2023, then slipped by 11.75% to -$371000.0 in 2024, then slipped by 9.7% to -$407000.0 in 2025.
- Per Business Quant, the three latest CRBP Other Working Capital Changes figures stand at -$29.5 million (Q2 2019), $25.5 million (Q1 2019), and $1292.0 (Q3 2016).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -407,000.00 |
| Sep 30, 2025 | -407,000.00 |
| Sep 30, 2025 | -407,000.00 |
| Jun 30, 2025 | -399,000.00 |
| Jun 30, 2025 | -399,000.00 |
| Jun 30, 2025 | -399,000.00 |
| Mar 31, 2025 | -384,000.00 |
| Mar 31, 2025 | -384,000.00 |
| Mar 31, 2025 | -384,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Dec 31, 2024 | -371,000.00 |
| Sep 30, 2024 | -365,000.00 |
| Sep 30, 2024 | -365,000.00 |
| Sep 30, 2024 | -365,000.00 |
| Jun 30, 2024 | -358,000.00 |
| Jun 30, 2024 | -358,000.00 |
| Jun 30, 2024 | -358,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Mar 31, 2024 | -343,000.00 |